Results 221 to 230 of about 9,385 (245)
Some of the next articles are maybe not open access.

Pharmacokinetics of dantrolene sodium in horses

Journal of Veterinary Pharmacology and Therapeutics, 1987
The pharmacokinetics of dantrolene sodium were investigated in horses following both intravenous (2 mg/kg) and intragastric (4 mg/kg) administration. Two ponies also received dantrolene sodium intravenously (2 mg/kg) in a pilot study to obtain preliminary kinetic data and to determine urinary and biliary excretion of the intact drug.
M. Clark   +5 more
openaire   +2 more sources

The Inhibition of Acetylcholinesterase by Dantrolene and Ondansetron

Drug Research, 2014
A virtual screening study has suggested that the skeletal muscle relaxant, dantrolene, and the antiemetic drug, ondansetron, may act as inhibitors of the enzyme acetylcholinesterase (AChE). Based on this proposal, the current study examines the AChE inhibitory properties of these drugs.Using AChE from human erythrocytes as enzyme source, it is shown ...
Jacobus P. Petzer   +2 more
openaire   +3 more sources

Dantrolene sodium increases calcium binding by human recombinant cardiac calsequestrin and calcium loading by sheep cardiac sarcoplasmic reticulum

Acta Physiologica, 2019
Dantrolene interacts with ryanodine receptors in skeletal and cardiac muscle affecting sarcoplasmic reticulum calcium release. Since dantrolene is lipophilic it could also affect intra‐sarcoplasmic reticulum calcium handling proteins such as ...
Christine M. Loescher   +2 more
semanticscholar   +1 more source

Pharmacokinetics of Intravenous Dantrolene in Children

Anesthesiology, 1989
To determine the pharmacokinetics of iv dantrolene and its metabolites in children, ten children 2-7 yr of age scheduled for minor elective surgery, were studied. After induction of anesthesia and tracheal intubation, dantrolene (2.4 mg/kg) was administered iv over 10.2 +/- 0.83 min.
H A Strong, Jerrold Lerman, M. E. McLeod
openaire   +3 more sources

Dantrolene in Porcine Malignant Hyperthermia

Anesthesiology, 1976
The effectiveness of intravenous administration of dantrolene in prevention and treatment of fulminant malignant hyperthermia (MH) initiated by halothene and succinylcholine (SCh) in genetically susceptible swine was assessed. In six animals, prior administration of dantrolene in doses of 5 mg/kg or more prevented MH, while 1 or 3 mg/kg attenuated MH ...
Richard A. Theye   +2 more
openaire   +3 more sources

Dantrolene—An Update

1987
Dantrolene sodium, a hydantoin derivative, relaxes skeletal muscle by a peripheral rather than a central action by inhibiting release of calcium from the sarcoplasmic reticulum (SR). Both resting and twitch tensions are decreased in the presence of dantrolene. The action of dantrolene on the SR may be indirect rather than direct.
openaire   +2 more sources

Pleuropericardial Reaction to Treatment With Dantrolene

JAMA: The Journal of the American Medical Association, 1979
Chronic pleural effusion occurred in three patients, one of whom also developed acute pericarditis. A fourth patient developed both pleural and pericardial effusions. All patients had been receiving dantrolene sodium for at least two months. The pleural fluid was a sterile exudate with pleural and peripheral blood eosinophilia in all patients.
R E Rocklin   +6 more
openaire   +3 more sources

In vitroantioxidant properties of dantrolene sodium

Pharmacological Research, 2001
Dantrolene sodium is a skeletal muscle relaxant, which inhibits intracellular Ca2+ release from the sarcoplasmic reticulum. The aim of this study is to examine possible in vitro antioxidant effects of dantrolene sodium. For this reason, the in vitro antioxidant effects of dantrolene sodium were studied using thiocyanate methods.
BUYUKOKUROGLU, Mehmet Emin   +3 more
openaire   +4 more sources

Dantrolene and “ecstasy”

Medical Journal of Australia, 1997
Michael A. Denborough, Ken C Hopkinson
openaire   +5 more sources

Dantrolene sodium and hepatic injury

Neurology, 1990
This is a report on hepatic adverse events associated with dantrolene therapy. All cases reported to the manufacturer are included, from all sources, through 1987. Of 122 cases containing sufficient data to analyze, 47 patients had asymptomatic transaminase elevations, 12 had additional mild (less than or equal to 2.5 mg/dl) hyperbilirubinemia, 36 had ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy